Physician profile
Jamie Fleming
NPI 1376922708
$6,408.90
in general payments reported to CMS, 2019-2025
12 companies · $524 in 2025
The $524 reported for 2025 was more than what 93% of Pediatric Anesthesiology providers received nationally (typical 2025 total: $40.62).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $2,086 · 2023: $1,583 · 2024: $2,091 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,379 · Travel and Lodging: $1,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,378.69 |
| Travel and Lodging | $1,818.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,109.10 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Nevro Corp. | $1,704.73 | 2022 | |
| Abbott Laboratories | $1,647.01 | 2022-2024 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $186.66 | 2025 | Iovera |
| Saluda Medical Americas, INC. | $173.07 | 2023-2024 | Evoke, Evoke Scs |
| Relievant Medsystems, INC. | $153.57 | 2022 | |
| Spr Therapeutics, INC | $137.82 | 2024 | Sprint Pns System |
| Allergan, INC. | $112.33 | 2022 | |
| Si-Bone, INC. | $87.69 | 2025 | |
| Convatec INC. | $63.07 | 2025 | |
| Stryker Corporation | $19.79 | 2023 | Multigen 2 |
| Nalu Medical, INC. | $14.06 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.